Hypertension: A new safety risk for patients treated with erenumab

Saely, S; Croteau, D; Jawidzik, L; Brinker, A; Kortepeter, C

Saely, S (corresponding author), US FDA, Div Pharmacovigilance 1, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.

HEADACHE, 2021; 61 (1): 202